A new blood test may help patients avoid chemotherapy in a bowel cancer trial.

Key Highlights :

1. A new blood test is being trialled to see if it can accurately predict if surgery has removed all of the cancer from a patient's bowel. If the test is successful, then chemotherapy would be unnecessary.

2. Around 50% of people with bowel cancer can be cured with surgery alone, and chemotherapy is often over-treating these patients. If the new blood test is successful, this would greatly improve their quality of life.

3. The test is being trialled at London's Royal Marsden Hospital. If it is successful, it could revolutionise treatment for bowel cancer within 5-8 years.

A ground-breaking blood test is being trialled in the UK that could revolutionise the way we diagnose and treat serious diseases. The test, known as a 'liquid biopsy', is a non-invasive way of collecting cells from a patient's blood for analysis. It could be used to diagnose a range of diseases, including cancer, and could even be used to monitor the effectiveness of treatments.

The test is being trialled by researchers at the University of Cambridge, and it could have a huge impact on the way we treat diseases. Liquid biopsies are a much more accurate way of collecting cells than traditional blood tests, and they can be done without any surgery. This means that they could be used to diagnose diseases in patients who are difficult to access, or who are not able to give blood.

The liquid biopsy test is still in its early stages, but it has already shown promise. The researchers have been able to use it to diagnose cancer in mice, and they are now looking to further develop the test. If the test is successful, it could revolutionise the way we treat diseases, and it could even be used to monitor the effectiveness of treatments.

Continue Reading at Source : nzherald